"Trump Tariff 'Liberation Day' is coming, the pharmaceutical industry may not be in the target line."

According to reports, President Trump is expected to announce a series of broader tariff measures on April 2 (Wednesday), which will not include any specific details on drug tariffs; This has been dubbed as a "liberation day" by Trump. Wall Street is preparing for Trump's "liberation day" tariff plan, which the Trump administration claims is a response to foreign "unfair trade practices" and an attempt to promote local manufacturing, but pharmaceutical companies can breathe a sigh of relief. Insiders revealed that in order to minimize the impact on the economy and buy time to shift production overseas, pharmaceutical companies are lobbying Trump to gradually increase tariffs rather than implement them all at once. Since the start of his second term, President Trump has repeatedly threatened to expand the tariff war to pharmaceutical products, but medical products have been exempt from trade wars for a long time due to their impact on public health. However, in anticipation of eventual tariffs on medical products imposed by the US, major pharmaceutical companies are now pushing to gradually increase tariffs to 25%, rather than implementing them from day one. One source stated: "From the pharmaceutical industry's perspective, the idea of gradually increasing tariffs is certainly present."